Relmada Therapeutics RLMD
NASDAQ RLMD
$3.21 -0.15 (-4.46%)
At close: Oct 21, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Receivables - Other (2016 - 2022)

Updated

Relmada Therapeutics' Receivables - Other came in at $512,432 for Q4 2022.

Analysis

Relmada Therapeutics (RLMD) Receivables - Other (2016 - 2022) Analysis & Trends

Going back to Q1 2020, Relmada Therapeutics' Receivables - Other data covers 4 quarters.

  • Receivables - Other carries a five-year compound annual growth rate of 17.1% (FY2017 to FY2022).
  • Going back by year, Receivables - Other was $177,000 in FY2019 and $7,617 in FY2018 (-96.7%).
  • The Q4 2022 figure represents the lowest quarterly Receivables - Other since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Relmada Therapeutics 361.29 Mn -197.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 512,432.00
Mar 31, 2022 3.61 Mn
Sep 30, 2021 1.61 Mn
Mar 31, 2020 7,529.00
Jun 30, 2019 177,000.00
Jun 30, 2018 7,617.00
Sep 30, 2017 150,617.00
Jun 30, 2017 232,597.00
Dec 31, 2016 2,350.00
Sep 30, 2016 2,350.00
Jun 30, 2016 231,942.00
API Access

Relmada Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=RLMD&period=max&api_key=YOUR_API_KEY